Related content

Safety and Efficacy of Carbamazepine Extended-Release Capsules in Patients With Bipolar Disorder: QD vs BID

By Ginsberg Lawrence  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 27-30

Informa Healthcare

Access to resources Recommend Favorite

Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study

By Huff R.M.   Tanganelli P.   Regesta G.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 257-262

Elsevier

Access to resources Recommend Favorite

Cancer Incidence in Patients With Schizophrenia or Bipolar Disorder: A Nationwide Population-Based Study in Taiwan, 19972009

By Lin Gen-Min   Chen Yu-Jung   Kuo De-Jhen   Jaiteh Lamin E. S.   Wu Yi-Chung   Lo Tzu-Shun   Li Yi-Hwei  

Schizophrenia Bulletin, Vol. 39, Iss. 2, 2013-03 ,pp. : 407-416

Oxford University Press

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: Depression vs. sub-threshold mixed state

By Mazza Marianna   Mandelli Laura   Zaninotto Leonardo   Nicola Marco Di   Martinotti Giovanni   Harnic Desiree   Bruschi Angelo   Catalano Valeria   Tedeschi Daniela   Colombo Roberto   Bria Pietro   Serretti Alessandro   Janiri Luigi  

Nordic Journal of Psychiatry, Vol. 65, Iss. 6, 2011-12 ,pp. : 419-426

Informa Healthcare

Access to resources Recommend Favorite